Embedding Indigenous Consent and Benefit‑Sharing into U.S. Psychedelic Drug Policy
Hook Imagine a world where the rush to bring psychedelic breakthroughs to the clinic does not trample the centuries-old stewardship of the very plants that make those breakthroughs possible. In 2024, several states have already decriminalized psilocybin, and the FDA is fast-tracking clinical trials. Yet the fast-track process can become